Aflac (AFL) Expected to Announce Quarterly Earnings on Tuesday

Aflac (NYSE:AFL) is anticipated to release its Q3 2025 results after the market closes on Tuesday, November 4th. Analysts expect Aflac to post earnings of $1.77 per share and revenue of $4.3577 billion for the quarter. Interested persons may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Wednesday, November 5, 2025 at 8:00 AM ET.

Aflac (NYSE:AFL) last released its earnings results on Monday, February 27th. The financial services provider reported $1.07 earnings per share for the quarter. The business had revenue of $5.91 billion for the quarter. Aflac had a return on equity of 15.08% and a net margin of 15.32%. On average, analysts expect Aflac to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Aflac Stock Performance

NYSE AFL opened at $107.19 on Monday. The company has a market cap of $57.33 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 2.93 and a beta of 0.86. The stock’s 50 day simple moving average is $108.61 and its 200-day simple moving average is $105.59. Aflac has a 1-year low of $96.95 and a 1-year high of $115.43. The company has a debt-to-equity ratio of 0.33, a current ratio of 0.11 and a quick ratio of 0.11.

Aflac declared that its Board of Directors has approved a share buyback program on Tuesday, August 12th that authorizes the company to buyback 100,000,000 outstanding shares. This buyback authorization authorizes the financial services provider to reacquire shares of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s board believes its stock is undervalued.

Aflac Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 2nd. Investors of record on Wednesday, August 20th were given a dividend of $0.58 per share. The ex-dividend date was Wednesday, August 20th. This represents a $2.32 dividend on an annualized basis and a yield of 2.2%. Aflac’s dividend payout ratio (DPR) is presently 52.61%.

Insider Buying and Selling at Aflac

In other news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction on Friday, August 8th. The stock was sold at an average price of $102.57, for a total value of $102,570.00. Following the completion of the sale, the director directly owned 25,105 shares of the company’s stock, valued at approximately $2,575,019.85. The trade was a 3.83% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Aflac

Institutional investors have recently modified their holdings of the company. Brighton Jones LLC grew its stake in shares of Aflac by 64.4% in the fourth quarter. Brighton Jones LLC now owns 14,570 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 5,708 shares in the last quarter. Bison Wealth LLC grew its stake in Aflac by 4.3% during the 4th quarter. Bison Wealth LLC now owns 4,402 shares of the financial services provider’s stock worth $455,000 after purchasing an additional 183 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in Aflac by 27.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 36,030 shares of the financial services provider’s stock worth $3,800,000 after purchasing an additional 7,784 shares in the last quarter. Headlands Technologies LLC acquired a new position in Aflac during the 2nd quarter worth $67,000. Finally, Hudson Bay Capital Management LP grew its stake in Aflac by 668.3% during the 2nd quarter. Hudson Bay Capital Management LP now owns 19,360 shares of the financial services provider’s stock worth $2,042,000 after purchasing an additional 16,840 shares in the last quarter. 67.44% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. JPMorgan Chase & Co. lifted their price objective on Aflac from $96.00 to $100.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 8th. Weiss Ratings reiterated a “buy (b-)” rating on shares of Aflac in a research report on Wednesday, October 8th. Evercore ISI set a $110.00 price objective on Aflac and gave the stock an “underperform” rating in a research report on Thursday, October 9th. UBS Group cut their target price on Aflac from $114.00 to $111.00 and set a “neutral” rating for the company in a research note on Wednesday, August 6th. Finally, Barclays reissued an “underweight” rating and set a $102.00 target price (up previously from $100.00) on shares of Aflac in a research note on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $109.90.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.